Jeffery W. Kelly
for elucidating the molecular basis of neurodegenerative and cardiac transthyretin diseases, and for developing tafamidis, a drug that slows their progression.
Affiliated at time of winning
La Jolla, United States
Recognition for work with lasting impact
for elucidating the molecular basis of neurodegenerative and cardiac transthyretin diseases, and for developing tafamidis, a drug that slows their progression.
La Jolla, United States